Reuters logo
BRIEF-Karo Pharma makes recommended cash offer for Norway's Weifa
August 24, 2017 / 6:06 AM / a month ago

BRIEF-Karo Pharma makes recommended cash offer for Norway's Weifa

Aug 24 (Reuters) - Karo Pharma AB

* Karo Pharma AB announces a recommended voluntary cash offer to acquire all shares in Weifa ASA

* Says cash offer at NOK 35 per Weifa share valuing total share capital of Weifa at approximately NOK 1.28 billion on a fully diluted basis

* Says recommended by board of directors of Weifa

* Says pre-acceptances of offer from shareholders together representing approximately 45.35% of issued share capital of Weifa and purchase agreements with holders of 1,735,716 share options

* Says offer values total share capital of Weifa at approximately NOK 1.28 billion on a fully diluted basis

* Says offer price represents a 10% premium to Weifa’s closing share price on 23 August 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below